Skip to main content
RecallsAboutBlog

Zydus Pharmaceuticals (USA) Inc

Zydus Pharmaceuticals (USA) Inc: 5 recalls listed since January 2026 across FDA.

By year

  • 20265

By agency

  • FDA5

By category

  • Drug5

All recalls (5)

Zydus Hydrocortisone Sodium Succinate for Injection

Hydrocortisone Sodium Succinate for Injection failed impurities and degradation specifications.

Moderate risk, FDA, , Drug impurity

Zydus Mirabegron Extended-Release Tablets

Mirabegron Extended-Release Tablets contain an impurity above specification.

Moderate risk, FDA, , Drug impurity

Zydus Erythromycin Tablets

Zydus Pharmaceuticals is recalling its Zydus Erythromycin Tablets, USP because of CGMP deviations and presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit.

Moderate risk, FDA, , Drug impurity

Zydus Pharmaceuticals Icosapent Ethyl Capsules

Icosapent Ethyl Capsules have red dots inside and melted capsules due to oxidized active ingredient.

Moderate risk, FDA, , Quality testing problem

Zydus Pharmaceuticals Icosapent Ethyl Capsules

Icosapent Ethyl capsules may be subpotent due to oxidation from leakage of capsule contents.

Moderate risk, FDA, , Wrong drug strength
Embed this list